This is complemented by reductions in sleep latency (time to fall asleep) and benefits in sleep quality throughout supplementation, positioning Sleeproot as a plant-based, melatonin-free alternative for brands addressing consumers’ demand for natural, effective sleep aids.
The new data, published in Advances in Complementary & Alternative Medicine, builds on last year’s study featured in Advances in Therapy, which demonstrated Sleeproot’s ability to reduce sleep latency as early as day three, improve sleep efficiency and support occasional anxiety during an 8-week period.
This further strengthens Sleeproot’s benefits as a botanical sleep solution, providing benefits for sleep duration on day one and benefits for sleep latency within the first 3 days of supplementation.
“We are thrilled to present these advancements, which highlight Sleeproot’s benefits for overall sleep quality,” said VP of Marketing at OmniActive.
“The results reflect a unique, plant-based approach to sleep support, offering consumers an effective, natural alternative sleep aid."
Sleeproot is a potent 2% extract from valerian roots, a plant well known to offer benefits for improving sleep quality and managing occasional mild anxiety.
Using green solvents, Sleeproot’s extraction process supports efficacy at a lower dose, overcoming the typical organoleptic challenges of valerian, making it ideal for various formulations, including capsules, gummies and ready-to-mix powders.
This flexibility enables brands to deliver a targeted, consumer-friendly sleep aid.